Last Updated: November 16, 2026

Details for Patent: 12,208,092

« Back to Dashboard


Which drugs does patent 12,208,092 protect, and when does it expire?

Patent 12,208,092 protects PALSONIFY and is included in one NDA.

This patent has twelve patent family members in twelve countries.

Summary for Patent: 12,208,092
Title:Compositions and methods for administering paltusotine to patients with hepatic impairment
Abstract:Provided are compositions and methods for administering paltusotine, or a pharmaceutically acceptable salt thereof, to a patient having hepatic impairment.
Inventor(s):Lance GOULET, William Humphreys, Ajay Madan, Sha Luo
Assignee: Crinetics Pharmaceuticals Inc
Application Number:US18/615,512
Patent Claim Types:
see list of patent claims
Use; Delivery; Dosage form;

Drugs Protected by US Patent 12,208,092

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Crinetics PALSONIFY paltusotine hydrochloride TABLET;ORAL 219070-001 Sep 25, 2025 RX Yes No 12,208,092 ⤷  Start Trial TREATMENT OF ADULTS WITH ACROMEGALY WHO HAVE HEPATIC IMPAIRMENT AND AN INADEQUATE RESPONSE TO SURGERY AND/OR FOR WHOM SURGERY IS NOT AN OPTION ⤷  Start Trial
Crinetics PALSONIFY paltusotine hydrochloride TABLET;ORAL 219070-002 Sep 25, 2025 RX Yes Yes 12,208,092 ⤷  Start Trial TREATMENT OF ADULTS WITH ACROMEGALY WHO HAVE HEPATIC IMPAIRMENT AND AN INADEQUATE RESPONSE TO SURGERY AND/OR FOR WHOM SURGERY IS NOT AN OPTION ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.